Mapsplatin 50 Injection
Marketer
AMPS Biotech Pvt Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Mapsplatin 50 Injection
Colorectal cancer is treated with the intravenous injection of Mapsplatin 50. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administration is strictly by a healthcare professional via intravenous injection, with dosage and frequency determined by your physician based on your specific condition and potentially adjusted over time. Adhere precisely to your doctor's instructions; improper usage or overdose can lead to severe adverse effects. While therapeutic benefits may not be immediately apparent (taking several weeks or months), discontinue use only under your doctor's guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. This medication may suppress blood cell production, increasing infection risk. Serious allergic reactions (such as mouth sores, skin rash, itching, or breathing difficulties) necessitate immediate medical attention. Regular blood tests are crucial to monitor blood cell counts, as well as heart, liver, and uric acid levels. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial medications. Potential drug interactions exist; inform your healthcare provider of all medications you are taking. Use during pregnancy or breastfeeding is contraindicated. Male infertility is a potential consequence; sperm cryopreservation should be discussed with your doctor beforehand. Post-administration dizziness may impair driving ability.
Uses of Mapsplatin 50 Injection
Colorectal cancer
Major Benefits of Mapsplatin 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mapsplatin 50 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Mapsplatin 50 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mapsplatin 50 Injection works:
Oncaspar 50 Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the cancerous cells' genetic blueprint (DNA and RNA), thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Mapsplatin 50 Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Mapsplatin 50 Injection during pregnancy is contraindicated due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Mapsplatin 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administering Mapsplatin 50 Injection or Oxaliplatin may induce adverse reactions impacting driving capabilities. These reactions can include dizziness, nausea, vomiting, and other neurological effects hindering ambulation, thereby potentially compromising safe driving.
KidneyCAUTION
The use of Mapsplatin 50 Injection requires careful consideration in patients exhibiting severe renal impairment, potentially necessitating dose modification. Consult your physician for guidance. Data regarding Mapsplatin 50 Injection use in such patients is limited. Dosage alterations are not suggested for individuals with mild to moderate kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should use Mapsplatin 50 Injection cautiously, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Mapsplatin 50 Injection :
Omit a Mapsplatin 50 Injection dose? Seek your physician's advice.
Facts to Know About Mapsplatin 50 Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Treatment Category | Cancer-fighting medications |
| Mechanism of Action | Platinum-based anti-cancer agents |
3,018 People bought this recently